These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8089635

  • 41. Serum angiotensin-converting enzyme levels in patients with chronic renal failure.
    Le Treut A, Chevet D, Guenet L, Leray G, Afiouni N, Le Pogamp P, Le Gall JY.
    Pathol Biol (Paris); 1983 Mar; 31(3):182-5. PubMed ID: 6304600
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
    Wolfe MW, Saad RM.
    Arch Intern Med; 1989 Jun; 149(6):1462-3. PubMed ID: 2543349
    [No Abstract] [Full Text] [Related]

  • 43. The effect of enalapril on proteinuria in patients with chronic glomerulonephritis and renal insufficiency.
    Yoshida A, Morozumi K, Takeda A, Koyama K, Ideura T, Ikeda M, Oikawa T.
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1249-52. PubMed ID: 8139137
    [Abstract] [Full Text] [Related]

  • 44. [The effects of prolonged treatment with gliclazide on the course of proteinuria and renal function in diabetic nephropathy].
    Lagrue G, Kazandjian M, Gumpelson A, Riveline B.
    Therapie; 1978 Nov; 33(5):629-37. PubMed ID: 741422
    [No Abstract] [Full Text] [Related]

  • 45. Assessment of progression of chronic renal failure--using reciprocal of serum creatinine.
    Muthusethupathi MA, Kumar SS, Sekaran L.
    J Assoc Physicians India; 1989 Mar; 37(3):213-6. PubMed ID: 2768164
    [Abstract] [Full Text] [Related]

  • 46. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G, Letizia C, Domenici A, Scavo D.
    Drugs Exp Clin Res; 1991 Mar; 17(5):263-9. PubMed ID: 1661665
    [Abstract] [Full Text] [Related]

  • 47. [Development of renal function in the transplanted patient with renal hypertension treated with enalapril].
    Guerin C, Genin C, Sabatier JC, Toulon J, Leroy G, Berthoux F.
    Nephrologie; 1987 Mar; 8(1):19-22. PubMed ID: 3035397
    [Abstract] [Full Text] [Related]

  • 48. ACE inhibition in chronic renal failure and in the treatment of diabetic nephropathy: focus on spirapril.
    Jardine AG, Elliott HL.
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S31-4. PubMed ID: 10499562
    [Abstract] [Full Text] [Related]

  • 49. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure.
    Hannedouche T, Landais P, Goldfarb B, el Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suo JM.
    BMJ; 1994 Oct 01; 309(6958):833-7. PubMed ID: 7950612
    [Abstract] [Full Text] [Related]

  • 50. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.
    Kamper AL, Nielsen OJ.
    Scand J Clin Lab Invest; 1990 Oct 01; 50(6):611-8. PubMed ID: 2247767
    [Abstract] [Full Text] [Related]

  • 51. COMPARISON OF LOSARTAN AND ENALAPRIL EFFECTS ON RENAL FUNCTION IN HYPERTENSIVE ADULTS WITH CHRONIC KIDNEY DISEASE AT A KENYAN REFERRAL HOSPITAL.
    Mugendi GA, Nyamu DG, Okalebo FA, Nyamweya NN, Ndwiga S, Mwangi M.
    East Afr Med J; 2014 Apr 01; 91(4):125-32. PubMed ID: 26859031
    [Abstract] [Full Text] [Related]

  • 52. Renal function during calcitriol therapy in chronic renal failure.
    Bertoli M, Luisetto G, Ruffatti A, Urso M, Romagnoli G.
    Clin Nephrol; 1990 Feb 01; 33(2):98-102. PubMed ID: 2311310
    [Abstract] [Full Text] [Related]

  • 53. [The treatment of hypertensive patients with renal insufficiency--a comparison of the blood pressure management in patients with diabetic nephropathy and patients with hypertensive nephropathy].
    Arima S, Abe K, Kudo K, Tsunoda K, Kohzuki M, Imai Y, Saito T, Sato H, Yokozawa S, Yoshinaga K.
    Nihon Jinzo Gakkai Shi; 1991 Oct 01; 33(10):1001-9. PubMed ID: 1770621
    [Abstract] [Full Text] [Related]

  • 54. [Serum beta 2-microglobulin as a index of the initiation of dialysis therapy for diabetic patients with chronic renal failure].
    Nakamura Y, Yasui A, Fukuda T, Yamamoto N, Ono T.
    Nihon Jinzo Gakkai Shi; 1991 Oct 01; 33(10):983-7. PubMed ID: 1770630
    [Abstract] [Full Text] [Related]

  • 55. Effect of ibopamine on the progression of chronic renal failure.
    Docci D, Pistocchi E, Turci F, Baldrati L.
    Clin Nephrol; 1986 Sep 01; 26(3):121-4. PubMed ID: 3769226
    [Abstract] [Full Text] [Related]

  • 56. Proteinuria in essential hypertension.
    Soni PS, Doifode DV, Kate SK.
    J Assoc Physicians India; 1994 May 01; 42(5):379-80. PubMed ID: 7829437
    [Abstract] [Full Text] [Related]

  • 57. [ACE inhibitors and kidney].
    Ritz E.
    Wien Med Wochenschr; 1990 Jan 31; 140(1-2):18-21. PubMed ID: 2408246
    [Abstract] [Full Text] [Related]

  • 58. [Characteristics of the patients with diabetic nephropathy with relatively low serum creatinine at the initiation of dialysis].
    Nakao T.
    Nihon Jinzo Gakkai Shi; 1990 Sep 31; 32(9):1025-31. PubMed ID: 2263024
    [Abstract] [Full Text] [Related]

  • 59. Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
    Gordge MP, Rylance PB, Neild GH.
    Clin Nephrol; 1992 Jan 31; 37(1):53-5. PubMed ID: 1541067
    [No Abstract] [Full Text] [Related]

  • 60. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control.
    Bergström J, Alvestrand A, Bucht H, Gutierrez A.
    Clin Nephrol; 1986 Jan 31; 25(1):1-6. PubMed ID: 3955903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.